On the morning of October 16, the signing ceremony, witnessed by Chongqing Medical University (CQMU), was held among the Management Committee of Chongqing High-Tech Industrial Development Zone, CQMU, and Square One Innovation Center. They will work together to develop an IVD medical industry cluster incubator/accelerator, with medical diagnose as the core, and dedicate to introducing the world’s latest technologies concerned with Chongqing for incubation and industrialization.

On the morning of October 16, the signing ceremony, witnessed by the Chongqing Medical University (CQMU), was held among the Management Committee of Chongqing High-Tech Industrial Development Zone, CQMU, and Square One Innovation Center.

In vitro diagnostic (IVD) products and services can be used to detect diseases, make prognoses and monitor a person’s overall health through tests done on samples such as blood or tissue that have been taken from the human body.

The platform and relevant projects have been incorporated in the Western (Chongqing) Science City construction plan. They have welcomed Spot Biosystems from the United States, Artron BioResearch Inc from Canada, and other healthcare companies from home and abroad to join the project.

The platform and relevant projects have been incorporated in the Western (Chongqing) Science City construction plan.

Ailong Huang, President of CQMU, said at the ceremony that China had a hungry market and huge development potential in the field of medical examination and IVD. However, it lacks representative diagnostic biomarkers and outstanding products for clinical tests, pointing out the country's crying need for original innovation.

Andrew Lee, President of Square One Innovation Center, addressed the ceremony online from Silicon Valley, noting the three parties would build a professional incubator/accelerator for medical diagnosis-based IVD products and work on the introduction of the world’s latest technologies concerned to Chongqing for incubation and industrialization.